News
BORAY
2.540
NaN%
--
UPSHER-SMITH LAUNCHES GENERIC VERSION OF RESTASIS® (CYCLOSPORINE OPHTHALMIC EMULSION 0.05%)
Reuters · 14h ago
Bora Pharma unit signs 10-year manufacturing deal with top-20 drugmaker
PUBT · 3d ago
Bora Pharma adds NTD 945.45 million guarantee for subsidiary Bora Global Ltd
PUBT · 05/13 16:09
Bora Pharma guarantees additional NTD 630,300 for subsidiary Upsher-Smith Laboratories
PUBT · 05/13 16:09
Bora Pharma launches 200,000-share buyback, sets NTD 300-600 price range
PUBT · 05/13 15:51
Bora Pharmaceuticals to attend First Securities investor conference
PUBT · 05/13 15:51
Bora Pharmaceuticals Q1 FY26 profit drops to NTD 32.45 million; revenue rises to NTD 4 billion
PUBT · 05/13 15:34
Bora Pharma injects USD 122.5 million into subsidiary Bora Pharma USA for working capital
PUBT · 05/11 23:12
Bora Pharmaceuticals buys MacroGenics Maryland CDMO assets for USD 122.5 million
PUBT · 05/11 23:00
MacroGenics sells GMP manufacturing operations to Bora for $122.5 million upfront payment
PUBT · 05/11 21:21
MACROGENICS INC - TO ENTER SUPPLY ARRANGEMENT WITH BORA FOR PROCESS DEVELOPMENT AND DRUG SUBSTANCE PRODUCTION FOR ITS INTERNAL PIPELINE NEEDS
Reuters · 05/11 21:20
Bora Pharmaceuticals April net sales fall 27.47% to NT$ 1.48 billion
PUBT · 05/11 13:36
Bora unit buys 10,840,000 SunWay Biotech shares in NTD 596.2 million private placement
PUBT · 05/05 12:34
Bora Pharma schedules board meeting to review Q1 2026 financial statements
PUBT · 05/05 12:34
Bora Pharmaceuticals issues 25,040 shares via employee stock option conversion at NTD 88.2-238
PUBT · 05/05 12:32
Bora Pharmaceuticals cancels 18,251 restricted shares, cuts capital by NTD 182,510
PUBT · 05/05 12:32
Bora Pharmaceuticals to attend Yuanta Securities investor conference
PUBT · 05/05 12:32
Bora Pharma injects NTD 624 million into subsidiary Bora Management Consulting
PUBT · 05/05 12:15
UPSHER-SMITH LAUNCHES NEW ONLINE RESOURCES TO SUPPORT THE DUCHENNE COMMUNITY
Reuters · 04/14 14:00
Bora Pharmaceuticals receives NTD 1.1 billion from fifth unsecured convertible bond sale
PUBT · 04/13 11:08
More
Webull provides a variety of real-time BORAY stock news. You can receive the latest news about BORA PHARMACEUTICALS CO LTD through multiple platforms. This information may help you make smarter investment decisions.
About BORAY
Bora Pharmaceuticals Co Ltd is a Taiwan-based company principally engaged in the agency and sales of western medicines, as well as the research, development, manufacture and sales of new drugs and health products. The Company's main products are categorized into prescription drugs and health care products, including central nervous drugs, cardiovascular drugs, antibiotics, antiviral agents, ophthalmic drugs, gastrointestinal drugs, foam ingots and health care products. In addition, the Company has biopharmaceutical technologies related to the development of cell lines for the production of protein drugs, the development and analysis of upstream and downstream processes, as well as the establishment of quality control and testing specifications and the creation of cell banks.